248 related articles for article (PubMed ID: 36614139)
1. Disabled-2 (
Price ZK; Lokman NA; Yoshihara M; Kajiyama H; Oehler MK; Ricciardelli C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614139
[TBL] [Abstract][Full Text] [Related]
2. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
Pandya DV; Parikh RV; Gena RM; Kothari NR; Parekh PS; Chorawala MR; Jani MA; Yadav MR; Shah PA
Mol Biol Rep; 2024 Jun; 51(1):701. PubMed ID: 38822973
[TBL] [Abstract][Full Text] [Related]
3. Loss of Disabled-2 Expression in Pancreatic Cancer Progression.
Hocevar BA
Sci Rep; 2019 May; 9(1):7532. PubMed ID: 31101868
[TBL] [Abstract][Full Text] [Related]
4. Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β.
Shapira KE; Hirschhorn T; Barzilay L; Smorodinsky NI; Henis YI; Ehrlich M
Mol Biol Cell; 2014 May; 25(10):1620-8. PubMed ID: 24648493
[TBL] [Abstract][Full Text] [Related]
5. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT).
Prunier C; Howe PH
J Biol Chem; 2005 Apr; 280(17):17540-8. PubMed ID: 15734730
[TBL] [Abstract][Full Text] [Related]
6. Disabled-2 downregulation promotes epithelial-to-mesenchymal transition.
Martin JC; Herbert BS; Hocevar BA
Br J Cancer; 2010 Nov; 103(11):1716-23. PubMed ID: 21063401
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-β-induced autophagy.
Jiang Y; Woosley AN; Sivalingam N; Natarajan S; Howe PH
Nat Cell Biol; 2016 Aug; 18(8):851-63. PubMed ID: 27398911
[TBL] [Abstract][Full Text] [Related]
8. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
10. Akt recruits Dab2 to albumin endocytosis in the proximal tubule.
Koral K; Li H; Ganesh N; Birnbaum MJ; Hallows KR; Erkan E
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1380-9. PubMed ID: 25253241
[TBL] [Abstract][Full Text] [Related]
11. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.
Wang WL; Chang WL; Yang HB; Wang YC; Chang IW; Lee CT; Chang CY; Lin JT; Sheu BS
Oncotarget; 2016 Nov; 7(44):71169-71181. PubMed ID: 27036032
[TBL] [Abstract][Full Text] [Related]
12. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin.
Jiang Y; He X; Howe PH
EMBO J; 2012 May; 31(10):2336-49. PubMed ID: 22491013
[TBL] [Abstract][Full Text] [Related]
13. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.
Hocevar BA; Prunier C; Howe PH
J Biol Chem; 2005 Jul; 280(27):25920-7. PubMed ID: 15894542
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2.
Zhou J; Hsieh JT
J Biol Chem; 2001 Jul; 276(30):27793-8. PubMed ID: 11371563
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of Disabled Homolog 2 (DAB2) in Immune Regulation.
Figliuolo da Paz V; Ghishan FK; Kiela PR
Front Immunol; 2020; 11():580302. PubMed ID: 33178208
[TBL] [Abstract][Full Text] [Related]
16. Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer.
Price ZK; Lokman NA; Sugiyama M; Koya Y; Yoshihara M; Oehler MK; Kajiyama H; Ricciardelli C
Cell Mol Life Sci; 2023 Oct; 80(11):320. PubMed ID: 37815603
[TBL] [Abstract][Full Text] [Related]
17. The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin β1 endocytosis.
Teckchandani A; Mulkearns EE; Randolph TW; Toida N; Cooper JA
Mol Biol Cell; 2012 Aug; 23(15):2905-16. PubMed ID: 22648170
[TBL] [Abstract][Full Text] [Related]
18. Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle.
Shah NN; Dave BP; Shah KC; Shah DD; Maheshwari KG; Chorawala MR; Parekh PS; Jani M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38502243
[TBL] [Abstract][Full Text] [Related]
19. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
Du L; Zhao Z; Ma X; Hsiao TH; Chen Y; Young E; Suraokar M; Wistuba I; Minna JD; Pertsemlidis A
Oncogene; 2014 Aug; 33(34):4307-15. PubMed ID: 24037530
[TBL] [Abstract][Full Text] [Related]
20. The clathrin adaptor proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake.
Wei J; Fu ZY; Li PS; Miao HH; Li BL; Ma YT; Song BL
J Biol Chem; 2014 Nov; 289(48):33689-700. PubMed ID: 25331956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
